{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:02:00Z","timestamp":1780048920488,"version":"3.53.1"},"reference-count":46,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":23,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","award":["CF\u20102022\u20102\/128"],"award-info":[{"award-number":["CF\u20102022\u20102\/128"]}],"id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["alz-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Alzheimer's &amp;amp; Dementia"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>INTRODUCTION<\/jats:title>\n                    <jats:p>Amyloid\u2010targeting therapies for Alzheimer's disease require regular MRI monitoring for amyloid\u2010related imaging abnormalities (ARIA). 3D scans are more sensitive but time intensive; ultra\u2010fast implementations could improve access and reduce burden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>Eighty scans from 20 participants were acquired with standard 2D fluid\u2010attenuated inversion recovery (FLAIR) and T2*\u2010gradient recalled echo (T2*\u2010GRE), or accelerated Wave\u2010controlled aliasing in parallel imaging (Wave\u2010CAIPI) 3D FLAIR and susceptibility\u2010weighted imaging (SWI) at 3 T. Two neuroradiologists graded ARIA\u2010E (edema\/effusion) and ARIA\u2010H (hemosiderin deposits). Bayesian models estimated sensitivity, specificity, severity agreement, and interchangeability between acquisitions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Accelerated sequences reduced acquisition time by up to 56%. Four participants had ARIA\u2010E and microbleeds; five had microbleeds alone. Sensitivity and specificity for ARIA\u2010E were identical (1.00; 0.94\u20130.95); severity was comparable. Replacing standard with accelerated FLAIR did not decrease severity agreement (interchangeability 1.4; 95% highest\u2010density interval [HDI] \u22123.6% to 5.4%). Fast SWI showed higher microbleed severity gradings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DISCUSSION<\/jats:title>\n                    <jats:p>Wave\u2010CAIPI offers fast high\u2010resolution FLAIR acquisitions with comparable performance for ARIA\u2010E monitoring. Wave\u2010CAIPI SWI provides high\u2010quality scans that may aid ARIA\u2010H interpretation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/alz.71297","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T03:36:07Z","timestamp":1774409767000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Accelerated 3D MRI for ARIA monitoring in Alzheimer's disease"],"prefix":"10.1002","volume":"22","author":[{"given":"Miguel","family":"Rosa\u2010Grilo","sequence":"first","affiliation":[{"name":"Dementia Research Centre, UCL Queen Square Institute of Neurology University College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dermot","family":"Mallon","sequence":"additional","affiliation":[{"name":"Lysholm Department of Neuroradiology National Hospital for Neurology and Neurosurgery  London UK"},{"name":"UCL Hawkes Institute University College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Thomas","sequence":"additional","affiliation":[{"name":"Dementia Research Centre, UCL Queen Square Institute of Neurology University College London  London UK"},{"name":"Department of Translational Neuroscience and Stroke, UCL Queen Square Institute of Neurology University College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Millie","family":"Beament","sequence":"additional","affiliation":[{"name":"Dementia Research Centre, UCL Queen Square Institute of Neurology University College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haroon R.","family":"Chughtai","sequence":"additional","affiliation":[{"name":"UCL Hawkes Institute University College London  London UK"},{"name":"Department of Medical Physics and Biomedical Engineering University College London  London UK"},{"name":"Advanced Research Computing (ARC) Centre University College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[{"name":"Research &amp; Clinical Translation Magnetic Resonance, Siemens Healthineers AG  Erlangen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Magill","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics London School of Hygiene &amp; Tropical Medicine  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian B.","family":"Malone","sequence":"additional","affiliation":[{"name":"Dementia Research Centre, UCL Queen Square Institute of Neurology University College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Meyer","sequence":"additional","affiliation":[{"name":"Research &amp; Clinical Translation Magnetic Resonance, Siemens Healthineers AG  Erlangen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoff J. M.","family":"Parker","sequence":"additional","affiliation":[{"name":"UCL Hawkes Institute University College London  London UK"},{"name":"Department of Medical Physics and Biomedical Engineering University College London  London UK"},{"name":"Bioxydyn Limited  Manchester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Triantafyllou","sequence":"additional","affiliation":[{"name":"Research and Scientific Collaboration Siemens Healthcare Ltd  Camberley UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Barkhof","sequence":"additional","affiliation":[{"name":"Lysholm Department of Neuroradiology National Hospital for Neurology and Neurosurgery  London UK"},{"name":"UCL Hawkes Institute University College London  London UK"},{"name":"Department of Medical Physics and Biomedical Engineering University College London  London UK"},{"name":"Department of Radiology and Nuclear Medicine Amsterdam UMC &amp; Vrije Universiteit  Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick C.","family":"Fox","sequence":"additional","affiliation":[{"name":"Dementia Research Centre, UCL Queen Square Institute of Neurology University College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine J.","family":"Mummery","sequence":"additional","affiliation":[{"name":"Dementia Research Centre, UCL Queen Square Institute of Neurology University College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2212948"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.13239"},{"key":"e_1_2_8_4_1","volume-title":"Kisunla (Donanemab\u2010azbt) Injection, for Intravenous Use: Highlights of Prescribing Information","author":"Eli Lilly and Company","year":"2024"},{"key":"e_1_2_8_5_1","volume-title":"LEQEMBI (Lecanemab\u2010irmb) Injection, for Intravenous Use: Highlights of Prescribing Information","author":"Eisai Inc","year":"2025"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.05.2351"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A3500"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.14283\/jpad.2023.30"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjpad.2025.100150"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12503"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A8469"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A1355"},{"key":"e_1_2_8_13_1","unstructured":"National Institute for Health and Care Excellence.Final draft guidance: lecanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer's disease. Published online 2025. Accessed November 7 2025.https:\/\/www.nice.org.uk\/guidance\/gid\u2010ta11220\/documents\/674"},{"key":"e_1_2_8_14_1","unstructured":"National Institute for Health and Care Excellence.Final draft guidance: donanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer's disease. Published online 2025. Accessed November 7 2025.https:\/\/www.nice.org.uk\/guidance\/gid\u2010ta11221\/documents\/674"},{"key":"e_1_2_8_15_1","unstructured":"Gov.UK.Life sciences competitiveness indicators 2024: summary. Published online July 11 2024.https:\/\/www.gov.uk\/government\/publications\/life\u2010sciences\u2010sector\u2010data\u20102024\/life\u2010sciences\u2010competitiveness\u2010indicators\u20102024\u2010summary"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468\u20101331.2012.03859.x"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41380\u2010023\u201002215\u20108"},{"key":"e_1_2_8_18_1","volume-title":"The 2019 National Memory Service Audit","author":"Cok L","year":"2020"},{"key":"e_1_2_8_19_1","volume-title":"National Audit of Dementia: Memory Assessment Services Spotlight Audit 2021","author":"Essel R","year":"2021"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.70156"},{"key":"e_1_2_8_21_1","unstructured":"Dementia Statistics. Accessed November 7 2025.https:\/\/www.alzint.org\/about\/dementia\u2010facts\u2010figures\/dementia\u2010statistics\/"},{"key":"e_1_2_8_22_1","unstructured":"Atlas of MS 2020\u2014The global faces of MS. Accessed Novemeber 7 2025.https:\/\/atlasofms.org\/map\/united\u2010kingdom\/epidemiology\/number\u2010of\u2010people\u2010with\u2010ms"},{"key":"e_1_2_8_23_1","unstructured":"Brain Tumour Statistics. Accessed November 7 2025.https:\/\/www.thebraintumourcharity.org\/get\u2010involved\/donate\/why\u2010choose\u2010us\/the\u2010statistics\u2010about\u2010brain\u2010tumours\/"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00247\u2010022\u201005529\u2010x"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/mrm.20819"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/mrm.20787"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/mrm.25347"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70341"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A7191"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A6295"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00330\u2010019\u201006574\u20101"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.1211"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2014.07.004"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v080.i01"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.21105\/joss.01541"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11222\u2010016\u20109696\u20104"},{"key":"e_1_2_8_37_1","doi-asserted-by":"crossref","unstructured":"HartigF.DHARMa: residual diagnostics for hierarchical (multi\u2010level\/mixed) regression models. Published online 2024. doi:10.32614\/CRAN.package.DHARMa","DOI":"10.32614\/CRAN.package.DHARMa"},{"key":"e_1_2_8_38_1","doi-asserted-by":"crossref","unstructured":"BryerJ SpeerschneiderK.Likert: analysis and visualization likert items. Published online 2025. doi:10.32614\/CRAN.package.likert","DOI":"10.32614\/CRAN.package.likert"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4"},{"key":"e_1_2_8_40_1","doi-asserted-by":"crossref","unstructured":"SivulaT MagnussonM MatamorosAA VehtariA.Uncertainty in Bayesian leave\u2010one\u2010out cross\u2010validation based model comparison.2025;arXiv:2008.10296. doi:10.48550\/arXiv.2008.10296","DOI":"10.1214\/25-BA1569"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.48136"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A5517"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2211001712"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00330\u2010004\u20102372\u20107"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00330\u2010017\u20105022\u20106"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A4248"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2012.06.033"}],"container-title":["Alzheimer's &amp; Dementia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/alz-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/alz.71297","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/alz-journals.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/alz.71297","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/alz-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/alz.71297","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:13:35Z","timestamp":1780046015000},"score":1,"resource":{"primary":{"URL":"https:\/\/alz-journals.onlinelibrary.wiley.com\/doi\/10.1002\/alz.71297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1002\/alz.71297"],"URL":"https:\/\/doi.org\/10.1002\/alz.71297","archive":["Portico"],"relation":{},"ISSN":["1552-5260","1552-5279"],"issn-type":[{"value":"1552-5260","type":"print"},{"value":"1552-5279","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"2025-11-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e71297"}}